Skip to main content

and
  1. No Access

    Article

    Patterns of treatment and outcomes of patients with brain-only metastatic breast cancer

    We characterized the risk factors and survival of metastatic breast cancer (MBC) patients with brain metastases (BrM) as the first and only site of disease in a large, retrospective cohort.

    Badr Id Said, Hany Soliman, Veronika Moravan, Sten Myrehaug in Journal of Neuro-Oncology (2023)

  2. No Access

    Article

    Trastuzumab emtansine increases the risk of stereotactic radiosurgery-induced radionecrosis in HER2 + breast cancer

    In this study, we investigate factors associated with radionecrosis (RN) in HER2 + (human epidermal growth factor receptor 2) patients with brain metastases (BrM) treated with stereotactic radiosurgery (SRS).

    Badr Id Said, Hanbo Chen, Katarzyna J. Jerzak, Ellen Warner in Journal of Neuro-Oncology (2022)